Gastrointestinal adverse events, including nausea, vomiting, diarrhea, constipation, and reduced oral intake, may limit dose escalation and lead to treatment interruption or discontinuation
Meanwhile, this article focuses on evaluating the evidence of the current effects of GLP-1RAs on patients body composition, muscle mass and function in clinical trials, deeply explores the dual effects and heterogeneity of its efficacy, and analyzes the translational dilemma existing between preclinical positive discoveries and clinical outcomes.Furthermore, for the elderly population, this article further discusses the tolerance and nutritional risks faced during the treatment of GLP-1RAs
Clinical MHV infection may be most commonly seen in young mice
2015;10:e0126764
Nie naley spoywa produktu, jeli tego samego dnia spoywasz inne produkty zawierajce zielon herbat